Genotypic guidance for chemotherapy choices

Drug Discovery Today

Volumn 10, Issue 9, 2005, Pages 608-

  Bradbury, Jane ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BH3 PROTEIN; BIM PROTEIN; BORTEZOMIB; PACLITAXEL; PROTEASOME INHIBITOR; TAXANE DERIVATIVE;

APOPTOSIS; CANCER CHEMOTHERAPY; CARCINOGENESIS; COMBINATION CHEMOTHERAPY; DRUG POTENCY; DRUG RESEARCH; GENOTYPE; HUMAN; MUTATION; NOTE; PRACTICE GUIDELINE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR;

EID: 18944365140     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(05)03435-5     Document Type: Short Survey

References (1)

1. Tan T-T Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy Cancer Cell 7 2005 227 238